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Abstract
Background: Stress echocardiography (SE) is a well-established diagnostic tool in assessing patients with suspected coronary
artery disease (CAD). Cardiovascular risk factors are used in the assessment of the probability of CAD. The link between the
outcome of SE and patients’ variables including cardiovascular risk factors, current medication and anthropometric variables has
not been widely investigated.
Objective: This study aims to use Machine Learning (ML) to predict significant CAD defined by positive SE results in patients
with chest pain based on patients’ anthropometrics, cardiovascular risk factors and medication as variables.
Methods: A ML framework is proposed to automate the prediction of SE results. The proposed framework consists of four
stages; feature extraction, pre-processing, feature selection and classification stage. A mutual information-based feature selection
method was used to investigate the amount of information that each feature carries to define the positive outcome of SE. Two
classification algorithms, Support Vector Machine (SVM) with Radial Basis Function (RBF) kernel, and Random Forest
classifiers have been deployed. Data from 529 patients have been used to train and validate the proposed framework. Their mean
age was 61 (±12 SD). The data consists of the anthropological data and cardiovascular risk factors such as gender, age, weight,
family history, diabetes, smoking history, hypertension, hypercholesterolaemia, prior diagnosis of CAD and prescribed
medications at the time of the test. The results of the SE were defined as outcome. A total of 82 patients had positive (abnormal)
and 447 negative (normal) results, respectively. The proposed framework has been evaluated using the whole dataset including
the cases with prior diagnosis of CAD. Five folds cross validation was used to validate the performance of the proposed
framework. We also investigated the model in the subset of patients with no prior CAD.
Results: The feature selection methods showed that prior diagnosis of CAD, sex, and prescribed medications such as angiotensin
convertase enzyme inhibitor or angiotensin receptor blocker were the features that shared the most information about the
outcome of SE. SVM classifiers showed the best trade-off between sensitivity and specificity and was achieved with three
features. The best trade-off between sensitivity and specificity for the whole dataset accuracy was 66.63% with sensitivity and
specificity 72.87%, and 67.67% respectively. However, for patients with no prior diagnosis of CAD only two features (sex and
angiotensin convertase enzyme inhibitor or angiotensin receptor blocker use) were needed to achieve accuracy of 70.32% with
sensitivity and specificity at 70.24%.
Conclusions: This pilot study shows that ML can predict the outcome of SE in detecting significant CAD based on only a few
features: patient prior cardiac history, gender, and prescribed medication. Further research recruiting higher number of patients
who underwent SE could further improve the performance of the proposed algorithm with the potential of facilitating patient’s
selection for early treatment / intervention with avoiding un-necessary downstream testing.
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Abstract 
Background:  Stress  echocardiography  (SE)  is  a  well-established  diagnostic  tool  for  suspected
coronary  artery  disease  (CAD).  Cardiovascular  risk  factors  are  used  in  the  assessment  of  the
probability  of  CAD. The link between the outcome of SE and patients’ variables  including risk
factors, current medication and anthropometric variables has not been widely investigated.
Objective: This study aims to use Machine Learning (ML) to predict significant CAD defined by
positive SE results in patients with chest pain based on anthropometrics, cardiovascular risk factors
and medication as variables. This could allow clinical prioritisation of patients with likely prediction
of CAD, thus saving clinician time and improving outcomes. 
Method: A ML framework is proposed to automate the prediction of SE results. The framework
consists of four stages; feature extraction, pre-processing, feature selection and classification stage. A
mutual  information-based  feature  selection  method  was  used  to  investigate  the  amount  of
information  that  each  feature  carries  to  define  the  positive  outcome  of  SE.  Two  classification
algorithms, Support Vector Machine (SVM) with Radial Basis Function (RBF) kernel, and Random
Forest classifiers have been deployed. Data from 529 patients was used to train and validate the
framework.  Their  mean  age  was  61  (±12  SD).  The  data  consists  of  anthropological  data  and
cardiovascular risk factors such as gender, age, weight, family history, diabetes, smoking history,
hypertension, hypercholesterolaemia, prior diagnosis of CAD and prescribed medications at the time
of the test. There were 82 positive (abnormal) and 447 negative (normal) SEbresults, respectively.
The framework was evaluated using the whole dataset including the cases with prior diagnosis of
CAD. Five folds cross validation was used to validate the performance of the framework. We also
investigated the model in the subset of patients with no prior CAD. 
Results:  The feature selection methods showed that prior diagnosis of CAD, sex, and prescribed
medications such as angiotensin convertase enzyme inhibitor or angiotensin receptor blocker were
the features that shared the most information about the outcome of SE. SVM classifiers showed the
best trade-off between sensitivity and specificity and was achieved with three features. Using only
these three features we achieved an accuracy of 67.63% with sensitivity and specificity 72.87%, and
66.67% respectively. However, for patients with no prior diagnosis of CAD only two features (sex
and angiotensin convertase enzyme inhibitor or angiotensin receptor blocker use) were needed to
achieve accuracy of 70.32% with sensitivity and specificity at 70.24%.
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Conclusion
This study shows that ML can predict the outcome of SE based on only a few features: patient prior
cardiac history,  gender,  and prescribed medication.  Further  research recruiting higher  number of
patients who underwent SE could further improve the performance of the proposed algorithm with
the potential of facilitating patient’s selection for early treatment / intervention with avoiding un-
necessary downstream testing. 
Keywords
stress echocardiography, coronary heart disease, risk factors, machine learning, feature selection, risk
prediction.
Introduction 
Cardiovascular disease (CVD) is the leading cause of death in Western societies [1]. In the UK, 7.4
million people are living with CVD, which is more than twice the number of people who suffer from
cancer and Alzheimer’s disease. More than 43,000 people under the age of 75 die each year due to
CVD costing national health services in the UK about £9 billion [2]. Coronary artery disease (CAD)
is the most common form of CVD, that may lead to sudden death [3].
Diagnosing CAD early can save lives and reduce risk of myocardial infarction and stroke. Diagnostic
procedures are typically performed in experienced cardiac centres to diagnose CAD and risk stratify
patients using tests such as a stress echocardiogram (SE). Stress echocardiography is a diagnostic
tool to assess the functionality of the heart and blood delivery under stress, such as treadmill or
bicycle exercise test or following administration of a drug such as dobutamine. Dobutamine is a
pharmacological agent that is administered intravenously to increases the heart rate in a similar way
that  would  occur  during  physical  exercise.  During   Dubutamine  SE,  incremental  doses  of
dobutamine  in  three  minutes  stages  is  administered  until  the  termination  of  the  test  criteria  is
achieved. The principle of SE is to increase the myocardial oxygen uptake/demand and in case the
supply is insufficient due to blocked heart arteries than echocardiographic features of this mismatch
can be detected by identifying regional wall motion abnormalities in the under-perfused heart muscle
region during the test. Echocardiographic images are acquired at rest, during the intermediate stage,
peak stress  and in the recovery. The classical criteria were used as a termination of the test i.e. target
heart  rate  achieved,  development  of  typical  chest  pain  symptoms with  or  without  regional  wall
motion abnormalities,  haemodynamically significant  arrhythmias or development  of symptomatic
hypotension.  Positive/abnormal  SE  is  defined  as  developments  of  new  regional  wall  motion
abnormalities. The definition of wall motion abnormalities was: hypokinesia if the wall thickness
was  maintained  and  the  endocardial  excursion  was  between  5  and  2mm;  akinesia  if  the  wall
thickness was reduced and the endocardial  excursion was less than 2mm; dyskinesia  if  the wall
thickness was reduced and the endocardial excursion was outward moving in systole. Dobutamine
SE has a sensitivity and specificity of 83% and 86% respectively [4]. A computer-based algorhythms
in image analysis and interpretation can play a significant role in the early diagnosis of CAD. Many
machine  learning-based  methods  have  been  devolved  for  image  analysis  to  aid  diagnosis  and
prognostic monitoring of CAD [5].
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Machine Learning (ML) is a term used to define computer algorithms that can be trained to learn the
patterns in training data. These algorithms are then effectively able to make predictions on unseen
data. The ability of ML techniques to learn from experience without any explicit guidelines for the
program or following any predefined rules is making these techniques increasingly popular in many
domains  [6].  ML in  healthcare  has  enormous  potential  in  supporting  healthcare  practitioners  in
decision  making,  enhancing  diagnostic  accuracy  and  in  reducing  healthcare  cost  [7].  Machine
learning  can  be  used  as  part  of  computer-aided  clinician  decision  support  system to  assimilate
patterns and act as an appropriate source of knowledge.
Several frameworks that employ ML for CAD prediction have been proposed [8]. These techniques
are used either for predicting the outcome of observations or discovering the hidden pattern and
structure in the data not readily recognisable to humans. The data often used for this kind of research
includes: patient anthropometric data, blood test results and data obtained from various investigation
modalities  used  in  the  diagnosis  of  CAD  such  as  Electrocardiography  (ECG),  Computed
Tomography Angiography, and Trans Thoracic Echocardiography (TTE) [8].
Clinical data have been used to predict coronary events: Voss et al. [9] used 10 years follow up data
for 5159 middle-age men with a 6.3% incidence of coronary events during that period of time. Multi-
Layer  Perceptron  (MLP)  was  used  to  build  their  model.  The  study  involved  57  clinical  and
laboratory variables to train the MLP. The reported results showed that the area under the curve was
0.89. Gharehchopogh and Khalifelu [10] employed deep learning as a learning algorithm for building
a prediction model, the learning algorithm was trained using data from 40 participants, including age,
sex, hypertension, and smoking. The reported classification accuracy was 0.85 for heart failure cases.
Another study [11] employed ML on clinical and laboratory data of 378,256 patients to predict the
first CVD event. The data used consisted of 30 attributes which included risk factors, laboratory data,
medications, and information about history of CVD and other chronic diseases such as poor mental
health, chronic obstructive pulmonary disease, kidney disease, and rheumatoid arthritis. The authors
applied four ML algorithms namely: random forest, logistic regression, gradient boosting, and neural
networks. The reported results showed that the best performance has been achieved by the neural
network algorithm with sensitivity of 67.5%, and specificity 70.7%.
In this pilot study we aimed to investigate the performance of a ML algorithm in predicting the SE
outcome in patients investigated for suspected CAD. Unlike previous  research,  we are testing a
sophisticated feature selection method to investigate the significance of cardiovascular risk factors,
current medication and anthropometric data in this prediction.
Methods 
Population and Data Sources 
The cohort of patients was derived from the Cardiology Department at Milton Keynes University
Hospital (MKUH). Anonymised clinical data had been extracted from patients’ electronic records,
predominantly based of the very detailed SE reports introduced prospectively by one author (AK), a
senior cardiologist, at the time of the development of SE services in the Hospital. We included all the
patients (N=563) examined using Dobutamine Stress Echo between 2002 and 2004 with available
data. However, we excluded 34 patients who had incomplete clinical data about their risk factors
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leaving 529 for this study. 
This  study uses  real  patients’ data  which can raise  some ethical  concerns,  such as  the patient’s
permission to  use their  data  and any confidential  information that  may exposed because of this
research. This was resolved by having hospital staff, the direct clinical care provider, anonymise the
records before they were sent for analysis. This study was registered by the Institutional Clinical
Governance Department, MKUH - Clinical governance project reference number: 33.
Table 1 summarises patients’ characteristics for the whole population and separately for the two
groups with positive and negative SE results respectively. All of these patients had a complete data
set for the anthropometric variables, risk factors such as gender, age, weight, family history (defined
as having a first degree relative who had a myocardial infarction or died suddenly below the age of
60),  diabetes,  smoking  status,  hypertension,  hypercholesterolemia,  prior  history  of  CAD,  the
prescribed medication related to CAD including: beta receptor blockers, calcium channel blockers,
angiotensin convertase enzyme inhibitor or angiotensin receptor blocker (ACEI/ARB), antiplatelets,
nitrates, statins, diuretics, as well as the SE results. The features in the table describe the number of
patients  who  have  that  risk  factor  positive,  for  example;  306  of  the  total  529  participants  had
hypertension, and 313 of them had abnormal serum cholesterol level
Table 1. Characteristics of patients and their SE outcome
Group Feature Total (529) SE-positive (82) SE-negative (447)
R
isk Factors
Sex M= 249, F= 280 M=61, F=21 M=188, F=257
Age 61.23 (±11.83 SD) 62.92 (±10.56 SD) 60.93 (±12.06 SD)
Weight 80.82 (±17.25 SD) 83.06 (±15.88 SD) 80.45 (±17.49 SD)
Hypertension (yes =1, no =0) 306 42 264
Hypercholesterolaemia(yes=1,no=0
)
313 50 263
Ex-smoker = -1
Non-smoker = 1
Smoker= 0
107
330
92
24
40
18
83
290
74
Diabetes Mellitus (yes =1, no =0) 99 19 80
Family History (yes =1, no =0) 223 35 188
Prior diagnosis of Coronary Artery
Disease (yes =1, no =0)
123 40 83
M
edications
Beta Receptor Blocker 
(yes =1, no =0)
281 58 223
Calcium Channel Blocker 
(yes =1, no =0)
137 22 115
(ACE-I/ARB) (yes =1, no =0) 258 59 199
Antiplatelet therapy 
(yes =1, no =0)
344 64 280
Nitrate (yes =1, no =0) 159 36 123
Statin (yes =1, no =0) 314 59 255
Diuretic (yes =1, no =0) 129 23 106
Proposed framework 
The collected data were used to predict the outcome of the stress test based on the patient’s clinical
information. Figure 1 shows the architecture of the framework that was used to study the risk factors
and the medication (referred to as features in this article), then we used these features to investigate
the prediction power of this clinical data. Raw data was received as a mixture of text and numerical
values. Therefore,  the first  stage in the proposed framework was the pre-processing stage where
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natural language processing was used to extract and quantify the needed information from the text
which included sex, age, weight, risk factors, medications, and the final outcome of the stress test
(positive/negative). The criteria shown in Table 1 were used to convert the text into numerical values.
Feature normalisation stage: this is the second stage used for continuous features (age and weight)
normalised using the formula:
( Normalised feature=
raw feature−mean
standrad deviation ).
Discretisation  stage: Two  normalised  features  were  then  discretised  using  the  Equal  Width
Discretisation (EWD) method [12]. In this method, the value of these features is allocated to one of
the decimal numbers between 1 and 10. This method divides the range of the feature values into 10
bins with equal width.
Width=(Maximum−minimum)
N
Where N is the number bins. Each feature value is assigned to a bin based on the range it falls into.
The reason of having discretisation stage is that most of the machine learning algorithms perform
better with discretised data [13]. Due the bias of the feature selection stage to the continuous features
[14], the discretisation stage is also needed to discretise these features before they are submitted to
the feature selection stage.
Feature selection stage: This is the fourth stage in this  framework, feature selection is a set of
techniques that are used to measure the significance of each feature for predicting the class label
(outcome of the stress test). In this study, the Joint Mutual Information Maximisation (JMIM) filter
feature selection method [15] is used to rank the features according the amount of information that
the feature adds to the selected subset. The method measures the amount of information that each
feature shares with the class. At the end of this stage all the features (sex, age, weight, risk factors,
and medications) will be ranked based on their significance in predicting the class label. This method
has been developed based on information theory [16], the mechanism of the method is explained
below.
The value of Mutual Information (MI) between any two of variable can be calculated using entropy.
It is the amount of uncertainty about a random variable. Suppose  F={f 1, f 2,…. f N }   is a discrete
variable, and C={c , c ,…. cN }  is a class label, the probability density function is
p ( f i )=
number of instants with value f i
N
.
The MI between F and C is defined as: 
The JMIM method employs the ‘maximum of the minimum’ criterion. The feature selected by the
JMIM method is the one that maximise the following goal function:
   
 1 1
,
( ; ) , log( )
( )
N M
i j
i j
i j i j
p f c
I F C p f c
p f p c 

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f JMIM=arg maxf i∈ F−S (¿min¿¿ f s∈S (I ( f i , f s ;C )))¿¿
Where I ( f i , f s ;C )  is the joint mutual information between the candidate feature and the features that
already selected in the previous iteration. The method employs the following forward greedy search
algorithm: 
1. Set  “initial set of n features;”  “empty set”.
2. (calculating  the  mutual  information  with  the  class  label)  for  each  feature  
compute  
3. Find the feature  that maximizes ; set  set .
4. (Greedy selection) Repeat until :
a) (Computation of the joint mutual information between variables) for all pairs of
variables  I ( f i , f s ;C )  with  compute I ( f i , f s ;C ) ,  if  it  is  not  already
available.
b) (Selection of the next feature) Choose feature.
f JMIM=arg maxf i∈ F−S (¿min¿¿ f s∈S (I ( f i , f s ;C )))¿¿
5. Output the set  containing the selected futures.
The method does not rank the features based on their individual discriminative power, it selects the
features that provide the most information as a subgroup, the interaction information between the
features affect is important in selecting the next significant feature. Therefore, if the list of submitted
features  is  changed the rank order  may be  different.  The whole data  is  submitted to  the JMIM
method  to  identify  the  significant  subset  of  features  (clinical  variables).  Smialowski  et  al.  [17]
reported that the feature selection stage should be included within folds-cross validation. However,
that can cause instability to the results  of the feature selection as submitting data with different
instances may lead to different values of probability density  function which consequently may lead
to changes in the order of the significant features. This paper aims to define the clinical variables that
can best precict the outcome of SE in the diagnosis of  CAD. Therefore, the whole data is used at the
feature selection stage to take the advantage of each valuable instance in the data. 
Classification  stage:  The  outcome  of  the  stress  test  is  predicted  at  this  stage.  Two alternative
classifiers  are  tested  at  this  stage:  Support  Vector  Machine  (SVM)  [18],  and  Random  Forest
classifiers [19]. The performance of each classifier was evaluated using 5 folds cross-validation. The
dataset is imbalanced, there are more than four times negative SE in the data than positive SE cases.
To overcome this problem more weight was given to the minority class, a ratio 4:1 has been used
with SVM, this means giving the minority class 4 times the weight that is given to the majority class.
Due to this skewness in the number of classes, classification accuracy will not be a good measure for
the performance, as it will be affected mainly by the ability of the classifier to recognise the majority
of classes correctly. Therefore, sensitivity and specificity were used to provide a measure for the
performance of the classifier in correctly classifying each class.
The data was randomly divided into five folds, four of them were used to train the classifier and one
for testing, then this process was repeated four more times, at each time four folds were used for
training and one of the folds that had never been used for testing before is used to test the classifier.
At  each  time  the  accuracy,  sensitivity,  and  specificity  were  calculated.  The  overall  accuracy,
sensitivity, and specificity are the average of the five.
F 
 if F 
if   ( ;  )iI C f   \ { };iF F f  
,  , i sf F f S    
S
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To find the subset of features that produces the best prediction performance, the classifier is trained
and tested after adding every feature according to its rank that identified at feature selection stage.
Figure 1. Experiment framework
Results
The  proposed  framework  was  used  to  study  the  whole  dataset  including  the  risk  factors  and
medications, and also it was used to study a sub-set of the dataset that excluded the cases with prior
CAD to investigate the influence of this variable on the performance of the model. Table 2 shows the
characteristics of this subset of patients referred in the rest of this paper as the sub-dataset (Table 2). 
The prevalence of abnormal SE was 15.5%. Four hundred and forty-seven patients had negative SE
results (84.5%). There were fewer women than men within the positive group, and the opposite in
those with negative SE results. Mean age 62.92 (±10.56 SD) and 60.93 (±12 SD) in the positive and
negative groups respectively. (Table1)
Feature selection: The feature selection stage was used to rank the features (clinical variables) in the
whole dataset, the significant features for the whole dataset are depicted by Table 3. The table shows
that for the whole cohort of patients’ CAD is the most significant feature for predicting SE outcome,
followed by sex, ACE-I/ARB usage, and smoking status.
Table 2. Characteristics of patients and their SE outcome in those with no prior ischaemic heart disease
Grou
p 
Feature SE-positive (42) SE-negative (364)
R
isk Factors
Sex M=33, F=9 M=147 F=217
Age 64.28(±9.80 SD) 60.96(±12.20 SD)
Weight 80.31(±13.18 SD) 80.46(±17.37 SD)
Hypertension 25 216
Hypercholesterolaemia 33 219
Ex-smoker
Non-smoker
Smoker
13
17
12
13
227
65
Diabetes Mellitus 6 67
Family History 17 132
Me Beta Receptor Blocker 28 166
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dications
Calcium Channel Blocker 9 89
ACE-I/ARB 32 148
Antiplatelet therapy 34 216
Nitrate 24 95
Statin 29 201
Diuretic 12 87
The results  showed that  prior CAD has the strongest power to distinguish between positive and
negative SE results. Sex appeared second because most of the positive cases were male, and most of
the  negative  were  female.  ACEI/ARB usage  is  the  only  applied  medication  among  the  5  most
significant  features.  On  the  other  hand,  age,  family  history,  and  diabetes  appeared  the  least
contributory features in this model. 
Table 3. Feature rankings
No Features 
1 Prior diagnosis of coronary artery disease 
2 Sex
3 ACE-I/ARB
4 Weight
5 Smoking status 
6 Beta Receptor Blocker 
7 Hypercholesterolaemia
8 Antiplatelet therapy 
9 Statin
10 Nitrate
11 Hypertension
12 Calcium Channel Blocker
13 Diuretic
14 Diabetes Mellitus
15 Family History
16 Age
Feature selection has been also applied on the sub-dataset. The order of the features was slightly
different as the prior CAD feature was excluded from the data.  Table 4 depicts the order of the
features, it shows that sex, ACE-I/ARB, cholesterol, nitrates, and smoking status are the five most
significant features. The only difference from the previous results when the whole dataset was used
is the swap between serum cholesterol and smoking status. Serum cholesterol status became the third
most significant feature followed by nitrates medication which was not among the most important.
Table 4. Feature ranking in the model for patients with no prior ischaemic heart disease
No Feature
1 Sex
2 ACE-I/ARB
3 Hypercholesterolaemia
4 Nitrate
5 Smoking status
6 Statin
7 Weight
8 Beta Receptor Blocker
9 Antiplatelet therapy 
10 Hypertension
11 Diuretic
12 Calcium Channel Blocker
13 Diabetes Mellitus
14 Family History
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15 Age
Classification: As mentioned earlier two classification algorithms were used in this study; namely:
SVM, and RF. The results showed that the performance of the two classifiers were close to each
other. However, the SVM slightly outperformed the RF classifier. In this paper only results produced
by the SVM are presented. 
a
b
Figure 2. Performance of SVM classifier: (a) classification accuracy ± standard error, (b) sensitivity and specificity ±
standard error.
Figure 2 shows that the best trade-off between sensitivity and specificity was achieved by the subset
of the most significant  four features (prior CAD, sex, weight, and ACE-I/ARB usage) which were
72.87%, and 66.67% respectively. The classification accuracy was 67.63%. The figure also showed
that when more features were added the sensitivity started to decrease and the specificity started to
increase therefore the accuracy is correlated more with the sensitivity due to this skewness in the
number of classes. This drop in the sensitivity means that the rest of the features are either redundant
or irrelevant for recognising the positive cases. When whole features were used only about 50% of
the  positive  cases  were  classified  correctly.  On  the  other  hand  RF  showed  a  slightly  lower
performance when the value of sensitivity, specificity, and classification accuracy were all the same
(69.2%); this figure has been achieved with the most significant four features. 
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The experiment was repeated on patients’ data with no known prior CAD. The performance of the
classification stage is depicted in figure 3. The sensitivity was slightly affected by excluding patients
with CAD as a feature from the data, however, the specificity increased. The classifier produced the
best  trade-off  between  the  sensitivity  and  specificity  with  only  using  two  features  (sex,  and
ACE-I/ARB usage) which were 70.24% for both of them. The accuracy also increased to 70.32%,
due to the increase of the specificity figure.
To test the robustness of the proposed framework, the experiment was repeated again, the model
trained without sex features. The results showed that the best performance has been achieved with
the best four features (prior CAD, ACE-I/ARB, Beta Receptor Blocker, and Smoking status) which
were 72.87% and 60.23 respectively. The accuracy decreased to 62.19%. 
a
b
Figure 3. Performance of SVM classifier for sub-dataset: (a) classification accuracy ± standard error, (b) sensitivity and
specificity ± standard error.
Discussion 
Feature selection is used as part of the proposed framework; these techniques have the capability to
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investigate  the  multidimensional  relation  between  the  features  and  the  class  label.  In  previous
research  [11] the  classifiers  were  used  to  rank  the  features  based  on  their  importance  for  the
classification algorithm, which are very specific to the classifier. This study employed the classifier
independent feature selection method (JMIM) to investigate the relation between features of clinical
data and class label (test  outcome) in  the context  of the features that  have been selected in the
previous iterations. This means that once we have selected the features they can be used with any
classifier. SVM and RF classifiers were tested in this study and SVM slightly outperformed RF in
our dataset.
The results of the feature selection and classification stages showed that prior CAD feature is the
most important risk factor for distinguishing between positive and negative cases. Sex, weight, and
smoking  status  are  among  the  group  of  most  significant  five  features,  and  the  only  current
medication that  is  within  this  group is  ACE-I/ARB. Hypertension,  diabetes,  and positive family
history are shown as the least significant features for the discrimination task. Only four features were
needed to achieve the best performance (prior CAD, sex, weight, and ACE-I/ARB usage), which
means by knowing only  this  information  about  the  patients,  the  proposed framework is  able  to
classify  72.87%  of  the  positive  cases,  and  66.67%  of  the  negative  cases  correctly  which
outperformed the previous study [11]. ACE-I/ARB is a used for several cardiovascular conditions
and secondary prevention after an acute coronary event. This feature carries information about these
conditions, that is why it is the most powerful predictor of SE outcome. For patients with no prior
history of CAD, knowing the sex and whether  the patient  is  taking ACE-I/ARB is sufficient  to
predict SE outcome in the majority of cases.
To study the robustness of the framework, the performance was tested without any information about
the  prior  diagnosis  of  CAD.  Once  this  was  tested  the  order  of  the  feature  became  different;
cholesterol  and nitrates medication became among the most significant  of the five features.  The
feature ‘weight’ was less significant in this model. This change in the order of the features can be
attributable to the information interaction between them. 
Because prior  diagnosis  of  CAD is  such a  power predictor  of  a  positive SE,  the  other  features
contribute so little information by comparison, and it is hard to see their value. However, once these
patients are removed from the dataset, we can see the predictive power of the other features for
patients with no previous history of CAD.
Features like age, diabetes and family history are shown to be less significant for discriminating
between positive and negative cases. It also showed that the information about the medications added
significant value and could enhance the discrimination power of the clinical data. It also showed that
interaction between features is important and can affect the order of the selected subset. Moreover,
increasing the granularity of the value of the risk factors may improve their discriminative power by
using continuous instead of categorial variables. 
Strength
To our knowledge, this is the first study that has investigated applying ML techniques to a simple
dataset  of  patient  anthropometrics  and  cardiovascular  risk  factor  profiles  and  cardioactive
medications to predict positive/abnormal SE results. The study also investigated the performance of
different  ML techniques  and  employed  a  sophisticated  feature  selection  method  to  study  the
significance  of  the  clinical  attributes.  This  method  considers  the  interaction  between  clinical
variables when analysing their significance and the class label. The proposed framework outperforms
the other tools that have been proposed in the literature [11] in predicting CAD by more than 9%.
The proposed framework can also be employed on data collected using other cardiovascular stress
tests aimed to detect inducible ischaemia.
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Limitations and future work
In this paper we report preliminary results using only 529 patients. The data includes only patients’
anthropometric and clinical data that has been collected during the patient’s hospital visit. Including
more data from patient medical records could enhance the generic behaviour of any proposed model
and improve the performance of the developed model. As we have a large dataset going back nearly
20 years, the model could be extended to predict mortality due to a cardiovascular event.
ML techniques  can  offer  the  very  promising  prospect  of  faster  and  more  accurate  diagnosis
(especially  for  high  risk  groups),  prioritising  higher  risk patients  and increasing  the  capacity  of
clinicians. However, it is well known that most ML techniques are considered to be “black-boxes”,
where the model produces difficult to interpret results. Despite the black-box nature of various ML
approaches, feature selection techniques can improve the understanding of the relationship between
the diagnosis and clinical attributes. Data visualisation methods can improve the understanding of the
produced model and interpretation of the output.
None of the clinical information detailing the results of the positive stress test such as wall motion
score index is included with the clinical data. Inclusion may further differentiate between high and
low risk patients. 
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Abbreviations
1-D: One dimension
ACE-I/ARB: Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
CAD: Coronary Artery Disease 
CNN: Convolutional Neural Network 
CVD: Cardiovascular Diseases 
ECG: Electrocardiogram
EWD: Equal Width Discretisation 
JMIM: Joint Mutual Information Maximisation 
MI: Mutual Information 
ML: Machine Learning 
MLP: Multi-Layer Perceptron 
RBF: Radial Basis Function
SD: Standard deviation
SE: Stress echocardiography 
SVM: Support Vector Machine
TTE: Trans Thoracic Echocardiography
Powered by TCPDF (www.tcpdf.org)
https://preprints.jmir.org/preprint/16975 [unpublished, non-peer-reviewed preprint]
